NIVELPHARMA
ActiveSummary
NIVELPHARMA has been active since 2003 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €64,316 and a net result of €65,451. Equity is growing by ~40.6% per year across the filed fiscal years. Its solvency ranks better than 25% of 12386 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.6% (low).
History
Acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
31-08
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema · 31 days late
2025
21-08
NBB filing
Annual accounts filed
fiscal year 2024 · full schema · 21 days late
2024
31-12
Financial
Equity above €100,000Eq €124,365 ▲36.2%
7 profitable years in a row build equity to €124,365.
29-08
NBB filing
Annual accounts filed
fiscal year 2023 · full schema · 29 days late
2023
31-12
Financial
Weakest financial yearnet €6,283 ▼78.7%
Net result drops to €6,283, the lowest in the series; recovery starts the following year.
31-07
NBB filing
Annual accounts filed
fiscal year 2022 · full schema
2022
01-06
NBB filing
Annual accounts filed
fiscal year 2021 · full schema
2021
31-12
Financial
Highest result since 2018net €65,713 ▲14%
Operating result €105,241, net result €65,713, both a record.
23-07
NBB filing
Annual accounts filed
fiscal year 2020 · full schema
2020
12-08
NBB filing
Annual accounts filed
fiscal year 2019 · full schema · 12 days late
2019
17-06
NBB filing
Annual accounts filed
fiscal year 2018 · full schema
2018
30-07
NBB filing
Annual accounts filed
fiscal year 2017 · full schema
2017
09-06
NBB filing
Annual accounts filed
fiscal year 2016 · full schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 5 acts read
About the unread acts
We know of 5 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.